IDH1 and central nervous system cancer: The major mutation in glioma is IDH1/IDH2, which is a key metabolic gene in the oxidative decarboxylation of isocitrate in tricarboxylic acid (TCA) cycle, converting isocitrate to ɑ-ketoglutarate as reducing NADP+ to NADPH26.